Cholangiocarcinoma
Bile duct cancer often diagnosed at incurable stage.
Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. It is a rare malignancy in the Western world but occurs at higher rates in Southeast Asia, particularly in parts of Thailand, where liver fluke infections are common. The disease is typically an adenocarcinoma and is often incurable at diagnosis, making early detection critical.
Quick Facts
- Pronounce
- k · ə · , · l · æ · n · dʒ · i · ou · , · k · a:r · s · I · ' · n · ou · m · ə · kə-LAN-jee-oh-KAR-sih-NOH-mə
- Field
- Oncology
- Symptoms
- Abdominal pain, yellowish skin, weight loss, generalized itching, fever
- Onset
- 70 years old
- Types
- Intrahepatic, perihilar, distal
- Risks
- Primary sclerosing cholangitis, ulcerative colitis, smoking, heavy alcohol use, infection with certain liver flukes, some congenital liver malformations
- Diagnosis
- Confirmed by examination of the tumor under a microscope
- Treatment
- Surgical resection, chemotherapy, radiation therapy, stenting procedures, liver transplantation
- Prognosis
- Generally poor
- Frequency
- 1–2 people per 100,000 per year (Western world)
Facts from the source article.
Lore & Background
Cholangiocarcinoma can affect any area of the bile ducts, either within or outside the liver. Tumors within the liver are called intrahepatic; those outside are extrahepatic; perihilar tumors at the liver exit are sometimes called Klatskin tumors. The disease is thought to develop through stages from hyperplasia to carcinoma, with chronic inflammation and impaired bile flow playing a role. Most tumors (>90%) are adenocarcinomas.
Reader's Guide
Cholangiocarcinoma is significant because it is typically incurable at diagnosis, with a five-year survival probability of less than 50% even when surgical removal is successful. Risk factors include primary sclerosing cholangitis, ulcerative colitis, cirrhosis, hepatitis B and C, liver fluke infections, and certain congenital malformations. In the Western world, rates of intrahepatic cholangiocarcinoma have increased. Diagnosis relies on blood tests, imaging, endoscopy, and microscopic examination of tumor cells. Palliative treatments include surgery, chemotherapy, radiation, and stenting. Complete surgical removal is possible in about a third of common bile duct cases, offering a chance of cure. The disease is rare in the West but common in Southeast Asia, where liver flukes are endemic.
Did You Know?
- Cholangiocarcinoma is typically an adenocarcinoma that forms glands or secretes mucin.
- Rates in parts of Thailand are 60 per 100,000 per year, compared to 0.5–2 per 100,000 in the Western world.
- Primary sclerosing cholangitis carries a lifetime risk of developing cholangiocarcinoma of 10–15%.
- Exposure to Thorotrast, a radiologic contrast medium banned in the 1950s, has been linked to cholangiocarcinoma 30–40 years later.
Frequently Asked Questions
Who is Cholangiocarcinoma?
Cholangiocarcinoma is a rare malignant tumor that takes root in the bile ducts, most often presenting as an adenocarcinoma. It is the cancer counterpart of the biliary system, affecting the tubes that carry bile from the liver to the intestine.
What are Cholangiocarcinoma's powers/role?
Its defining trait is an ability to stay clinically silent until it reaches an advanced, frequently incurable stage, which is why most patients are diagnosed too late for curative surgery. It typically strikes people in their 70s in the general population, though those with primary sclerosing cholangitis face risk as early as their 40s.
Why is Cholangiocarcinoma important?
It serves as a textbook example of how a chronic parasitic infection—specifically liver flukes—can drive cancer at dramatically elevated rates, with Thailand reporting roughly 60 cases per 100,000 people annually compared to just 0.5–2 per 100,000 in Western countries. This stark geographic disparity highlights the powerful link between long-standing biliary infection and malignant transformation.
What's Cholangiocarcinoma's origin story?
In many Southeast Asian cases the root cause traces back to chronic liver-fluke infection, whose persistent presence in the bile ducts triggers ongoing inflammation and cellular damage that eventually tips tissue toward malignancy. This infectious trigger is the key reason the disease clusters in regions where those parasites are endemic.
More in Infectious causes of cancer 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced